Anixa Biosciences INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Michael Catelani increased his beneficial ownership in Anixa Biosciences, Inc. to 7.0% through market purchases and stock option exercises, including a new grant.
NASDAQ
SCHEDULE 13D/A: Anixa Biosciences Insider Amit Kumar Increases Stake to 16.3%
Anixa Biosciences Inc. reports that insider Amit Kumar has increased his beneficial ownership in the company to 16.3% of outstanding common stock, up from 15.1%.
NASDAQ
SCHEDULE 13D/A: Anixa Biosciences Insider Amit Kumar Boosts Stake to 15.1% Through Option Grants and Purchases
Dr. Amit Kumar, a key insider at Anixa Biosciences Inc., has increased his beneficial ownership in the company to 15.1% of outstanding common stock, primarily driven by new stock option grants and market purchases.